ArticleFrontiers in immunology2025

Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.

Linan Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.